ClinicalTrials.Veeva

Menu

Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome

Medical College of Wisconsin logo

Medical College of Wisconsin

Status

Completed

Conditions

Preterm Birth

Treatments

Procedure: Sodium algorithm

Study type

Interventional

Funder types

Other

Identifiers

NCT05546814
IRBNet 1846631

Details and patient eligibility

About

The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status.

from this study will help us develop a better treatment for in the future.

Full description

Premature infants are at an increased risk of postnatal growth failure and as well as developing short or long-term impaired neurodevelopment and cardio metabolic health.

For many years, it has been recognized that ideal growth is attainable with sufficient sodium intake and a positive sodium balance. The results of this study could have a significant impact on the care of preterm infants.

Infants will be randomized into one of two groups. One group will receive sodium supplementation as guided by a urine sodium concentration algorithm, one group will be managed by current standards. Randomization will occur at 2 weeks of postnatal age

Standard of care group Care for the participant will remain the same as if they were not in the study. Nutritional information, including sodium intake will be collected on three separate days weekly for 8 weeks. Stool samples will be collected for determining intestinal microbiome at 2 weeks, 5 weeks, 8 weeks and the day they are discharged from the hospital.

The study team will also collect detailed health information from participants hospital stay from the medical chart. Which will include gestational age, birth weight, sex, race ,ethnicity, mode of delivery and exposure to any steroids, antibiotics and clinical diagnoses.

Sodium supplementation group:

Participants will receive sodium supplementation per the urine sodium concentration algorithm. Urine sodium will be determined weekly, and if urine sodium concentration is below set value, dietary sodium supplementation is provided.

Enrollment

6 patients

Sex

All

Ages

25 to 30 weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Birthweight >500 grams and
  • Gestational age at least 25 0/7weeks but less than 30 weeks.
  • <14 days of age at time of randomization

Exclusion criteria

  • Non-English speaking parents
  • Major congenital anomalies
  • grade underlying renal dysfunction (serum creatinine > 1.0 mg/dL or increase of >0.3 mg/DL between any two consecutive measurements)
  • use of diuretics at the time initiation of intervention (approximately 14 days of age) But this is not completely an exclusion-the research can wait 2 days and at the time of 2 week time period of the study we can re check their levels
  • any structural genitourinary criteria.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

6 participants in 2 patient groups

Sodium algorithm
Experimental group
Description:
Starting at 2 weeks of age, the sodium algorithm group will be started based on their sodium levels. This will be adjusted weekly based on weight gain and sodium levels.
Treatment:
Procedure: Sodium algorithm
Control
No Intervention group
Description:
Subjects will be cared for by current protocols

Trial contacts and locations

1

Loading...

Central trial contact

Elizabeth Awe, BA; Jeffrey Segar, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems